These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 18457614)

  • 1. Thrombolysis in antiphospholipid syndrome: current hematologic perspectives.
    McNall-Knapp RY
    Curr Rheumatol Rep; 2008 Jan; 10(1):62-6. PubMed ID: 18457614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An insight into the pathophysiology of thrombosis in antiphospholipid syndrome.
    Palomo IG; Segovia FM; Alarcon ML; Fuentes BY; Pereira JG; Rojas A; Forastiero R
    Front Biosci; 2007 May; 12():3093-103. PubMed ID: 17485284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Some antiphospholipid antibodies bind to hemostasis and fibrinolysis proteases and promote thrombosis.
    Chen PP; Yang CD; Ede K; Wu CC; FitzGerald JD; Grossman JM
    Lupus; 2008 Oct; 17(10):916-21. PubMed ID: 18827056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Some antiphospholipid antibodies bind to various serine proteases in hemostasis and tip the balance toward hypercoagulant states.
    Chen PP; Wu M; Hahn BH
    Lupus; 2010 Apr; 19(4):365-9. PubMed ID: 20353971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prothrombotic mechanisms based on the impairment of fibrinolysis in the antiphospholipid syndrome.
    Forastiero R; Martinuzzo M
    Lupus; 2008 Oct; 17(10):872-7. PubMed ID: 18827051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probing antiphospholipid-mediated thrombosis: the interplay between anticardiolipin antibodies and endothelial cells.
    Pierangeli SS; Harris EN
    Lupus; 2003; 12(7):539-45. PubMed ID: 12892395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
    Arnout J
    Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiphospholipid antibodies in neonates with stroke--a unique entity or variant of antiphospholipid syndrome?
    Berkun Y; Simchen MJ; Strauss T; Menashcu S; Padeh S; Kenet G
    Lupus; 2014 Sep; 23(10):986-93. PubMed ID: 24729280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiphospholipid antibodies: update on detection, pathophysiology, and treatment.
    de Groot PG; Derksen RH
    Curr Opin Hematol; 2004 May; 11(3):165-9. PubMed ID: 15257015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antiphospholipid syndrome.
    Wautrecht JC
    Acta Neurol Belg; 2002 Dec; 102(4):158-62. PubMed ID: 12534241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of antiphospholipid (aPL) antibodies among patients with chronic thromboembolic pulmonary hypertension: a systematic review and meta-analysis.
    Cheng CY; Zhang YX; Denas G; Du Y; Jing ZC; Pengo V
    Intern Emerg Med; 2019 Jun; 14(4):521-527. PubMed ID: 30603858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiphospholipid antibodies and the antiphospholipid syndrome: pathogenic mechanisms.
    Pierangeli SS; Chen PP; Raschi E; Scurati S; Grossi C; Borghi MO; Palomo I; Harris EN; Meroni PL
    Semin Thromb Hemost; 2008 Apr; 34(3):236-50. PubMed ID: 18720303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiphospholipid syndrome and asymptomatic carriers of antiphospholipid antibody: prospective analysis of 404 individuals.
    Girón-González JA; García del Río E; Rodríguez C; Rodríguez-Martorell J; Serrano A
    J Rheumatol; 2004 Aug; 31(8):1560-7. PubMed ID: 15290736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelets and the antiphospholipid syndrome.
    Urbanus RT; Derksen RH; de Groot PG
    Lupus; 2008 Oct; 17(10):888-94. PubMed ID: 18827053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of thrombin antibodies in patients with antiphospholipid syndrome.
    Miesbach W; Matthias T; Scharrer I
    Ann N Y Acad Sci; 2005 Jun; 1050():250-6. PubMed ID: 16014540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiological insights into the antiphospholipid syndrome.
    Lackner KJ; Manukyan D; Müller-Calleja N
    Hamostaseologie; 2017 Aug; 37(3):202-207. PubMed ID: 27786332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New targeted therapies for treatment of thrombosis in antiphospholipid syndrome.
    Pierangeli SS; Vega-Ostertag ME; González EB
    Expert Rev Mol Med; 2007 Nov; 9(30):1-15. PubMed ID: 17997880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiology of the catastrophic antiphospholipid syndrome (CAPS).
    Triplett DA; Asherson RA
    Am J Hematol; 2000 Oct; 65(2):154-9. PubMed ID: 10996834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical significance of antiphospholipid antibodies].
    Atsumi T; Koike T
    Rinsho Byori; 1998 Apr; 46(4):297-302. PubMed ID: 9594618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New insights on disorders of haemostasis in the antiphospholipid syndrome].
    Zawilska K
    Pol Arch Med Wewn; 2006 May; 115(5):491-9. PubMed ID: 17195368
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.